An epigenetic modification that occurs in a major cell type in the brain's reward circuitry controls how stress early in life increases susceptibility to additional stress in adulthood, researchers at the have learned. In a study in Nature Neuroscience, the team also reported that a small-molecule inhibitor of the enzyme responsible for this modification, currently being developed as an anti-cancer drug, was able to reverse increased vulnerability to lifelong stress in animal models.
"It has long been known that stress exposures throughout life control lifelong susceptibility to subsequent stress. Here we discovered a key molecular mechanism that mediates the lasting effects of that stress," says lead author. "In so doing, we generated an actionable biological target for treating early-life stress-induced susceptibility, which could open the door to potential clinical investigations of this pharmacological target for controlling stress-associated depressive disorders."
A lifelong history of stress is the strongest known risk factor for depression in humans. Previous studies have shown that early-life stress increases the risk of adult depression as much as threefold, depending on its timing, intensity, and specific features. Early-life stress is also known to increase the likelihood of behavioral susceptibility to stress later in life, and to have particularly strong effects on the nucleus accumbens, an essential component of the brain's reward system.
The study focused on epigenetic modifications within cells; these are chemical changes in the activity of genes that are not triggered by our inherited DNA code, but by molecules that regulate when, where, and to what degree our genetic material is activated. Researchers identified a previously unknown epigenetic mechanism that mediates the lasting effects of early-life stress--a mechanism known as H3K79me2 (demethylation of Lysine 79 of Histone H3) --in the nucleus accumbens. Early-life stress induces this mechanism selectively in D2-type medium spiny neurons of the nucleus accumbens and thereby reprograms the cells to increase vulnerability to a second episode of stress in adulthood.
The discovery of this mechanism involved unbiased approaches of inquiring which epigenetic modification--out of many hundreds--is most likely to mediate the effects of early-life stress in the nucleus accumbens. The researchers used a technique called proteomics to reveal that H3K79me2 is the epigenetic modification most highly regulated by early-life stress in this brain region and, in parallel, used RNA sequencing to show that the most highly regulated epigenetic enzyme is DOT1L, which catalyzes H3K79me2.
The importance of using an unbiased or open-ended approach to identify crucial mechanisms of disease pathophysiology was emphasized by the study's senior author. "Through this approach we were able to uncover the essential role played by this one type of histone modification out of many hundreds in mediating the ability of stress early in life to increase susceptibility to stress and potentially depression over a lifetime."
The team further showed that manipulation of the enzyme DOT1L in D2 medium spiny neurons of the nucleus accumbens bidirectionally controls stress susceptibility. That is, increasing DOT1L in this cell type increases stress vulnerability in animal models, while decreasing DOT1L has the opposite effect. "Through the use of RNA sequencing we then demonstrated that DOT1L overexpression dramatically recapitulates the gene expression changes that occur from early life stress, whereas DOT1L knockdown dramatically blocks the ability of early life stress to produce gene expression changes," explains the senior author.
This investigation set the stage for researchers to test the effect of a selective, small-molecule inhibitor of DOT1L, pinometostat, now in advanced clinical trials for treating acute myeloid leukemia. In the first exploration of the drug's effect on neuropsychiatric disease models, the team found that twice-daily injections of the inhibitor reversed the susceptibility-priming effects of early life stress on adult animals, without producing detectable side effects.
"We're greatly encouraged by these findings which support the possible use of the novel early life stress mechanism we identified for therapeutic purposes," says the lead. "They reveal a fundamentally new pathway for the development of improved treatments for depression, which are urgently needed given that more than one-third of all individuals with this syndrome are inadequately treated with current therapeutics."
https://www.mountsinai.org/about/newsroom/2021/mount-sinai-scientists-discover-an-epigenetic-mechanism-contributing-to-lifelong-stress-susceptibility
https://www.nature.com/articles/s41593-021-00814-8
Early life stress in neurons is mediated by epigenetic mechanism
- 1,268 views
- Added
Edited
Latest News
How tumor stiffness alters…
By newseditor
Posted 06 Jun
Neural circuit involved in…
By newseditor
Posted 06 Jun
Signaling mechanism in live…
By newseditor
Posted 05 Jun
Statin prevents cancer deve…
By newseditor
Posted 05 Jun
Predicting recovery in pati…
By newseditor
Posted 05 Jun
Other Top Stories
A mouse model for a devastating genetic deficiency
Read more
Could genetics influence what we like to eat?
Read more
Genes Responsible for Severe Congenital Heart Disease Identified
Read more
Genetic variant that protects against heart disease identified!
Read more
CRISPR gene editing can cause hundreds of unintended mutations
Read more
Protocols
Clinical and CSF single-cel…
By newseditor
Posted 05 Jun
ChatGPT-assisted deep learn…
By newseditor
Posted 04 Jun
Turning the tide in aggress…
By newseditor
Posted 03 Jun
Mapping medically relevant…
By newseditor
Posted 01 Jun
Accessible high-speed image…
By newseditor
Posted 30 May
Publications
Cytosolic pH is a direct ne…
By newseditor
Posted 06 Jun
Control of feeding by a bot…
By newseditor
Posted 06 Jun
BCAA-nitrogen flux in brown…
By newseditor
Posted 05 Jun
Mitochondrial GRIM19 Loss I…
By newseditor
Posted 05 Jun
Cofilactin rod formation me…
By newseditor
Posted 05 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar